Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2004 | 06-2003 | 06-2002 | 06-2001 | 06-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,360 | 5,820 | 7,160 | 640 | 1,220 |
| Receivables | 940 | 1,230 | 230 | 190 | 80 |
| Inventories | 0 | 250 | 780 | 2,450 | 4,080 |
| Other current assets | 40 | 70 | 70 | 100 | 20 |
| TOTAL | $12,340 | $7,370 | $8,240 | $3,380 | $5,400 |
| Non-Current Assets | |||||
| PPE Net | 1,850 | 1,490 | 490 | 800 | 1,420 |
| Other Non-Current Assets | 24,680 | 21,380 | 24,250 | 35,490 | 2,010 |
| TOTAL | $26,530 | $22,870 | $24,740 | $36,290 | $3,430 |
| Total Assets | $38,880 | $30,240 | $33,000 | $39,680 | $8,840 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,270 | 2,710 | 1,690 | 0 | 0 |
| Other current liabilities | 1,380 | 250 | 170 | 1,610 | 1,270 |
| TOTAL | $4,650 | $2,960 | $1,860 | $1,610 | $1,270 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 110 | -110 | 20 | 0 | 0 |
| TOTAL | $110 | $-110 | $20 | $N/A | $N/A |
| Total Liabilities | $4,770 | $2,850 | $1,890 | $1,610 | $1,270 |
| Shareholders' Equity | |||||
| Common Shares | 57,070 | 39,680 | 39,350 | 53,950 | 20,210 |
| Retained earnings | 0 | -12,980 | -8,820 | -15,980 | -12,780 |
| Other shareholders' equity | -22,970 | 690 | 570 | 90 | 140 |
| TOTAL | $34,100 | $27,390 | $31,100 | $38,060 | $7,570 |
| Total Liabilities And Equity | $38,870 | $30,240 | $32,990 | $39,670 | $8,840 |